img

Global TIGIT Therapies Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global TIGIT Therapies Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal TIGIT Therapies Market
Global TIGIT Therapies market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, TIGIT Therapies industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, TIGIT Therapies key companies include Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences and Innovent Biologics, etc. Roche, Merck, AstraZeneca are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of TIGIT Therapies were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole TIGIT Therapies market and estimated to attract more attentions from industry insiders and investors.
TIGIT Therapies can be divided into Monotherapy and Combination Therapy, etc. Monotherapy is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
TIGIT Therapies is widely used in various fields, such as Cell Carcinoma and Solid Tumor, etc. Cell Carcinoma provides greatest supports to the TIGIT Therapies industry development. In 2022, global % revenue of TIGIT Therapies went into Cell Carcinoma filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global TIGIT Therapies market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global TIGIT Therapies market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Segment by Type
Monotherapy
Combination Therapy

Segment by Application


Cell Carcinoma
Solid Tumor
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, TIGIT Therapies introduction, etc. TIGIT Therapies Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of TIGIT Therapies
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TIGIT Therapies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global TIGIT Therapies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cell Carcinoma
1.3.3 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global TIGIT Therapies Market Perspective (2018-2029)
2.2 Global TIGIT Therapies Growth Trends by Region
2.2.1 TIGIT Therapies Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 TIGIT Therapies Historic Market Size by Region (2018-2024)
2.2.3 TIGIT Therapies Forecasted Market Size by Region (2024-2029)
2.3 TIGIT Therapies Market Dynamics
2.3.1 TIGIT Therapies Industry Trends
2.3.2 TIGIT Therapies Market Drivers
2.3.3 TIGIT Therapies Market Challenges
2.3.4 TIGIT Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue TIGIT Therapies by Players
3.1.1 Global TIGIT Therapies Revenue by Players (2018-2024)
3.1.2 Global TIGIT Therapies Revenue Market Share by Players (2018-2024)
3.2 Global TIGIT Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of TIGIT Therapies, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global TIGIT Therapies Market Concentration Ratio
3.4.1 Global TIGIT Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TIGIT Therapies Revenue in 2022
3.5 Global Key Players of TIGIT Therapies Head office and Area Served
3.6 Global Key Players of TIGIT Therapies, Product and Application
3.7 Global Key Players of TIGIT Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 TIGIT Therapies Breakdown Data by Type
4.1 Global TIGIT Therapies Historic Market Size by Type (2018-2024)
4.2 Global TIGIT Therapies Forecasted Market Size by Type (2024-2029)
5 TIGIT Therapies Breakdown Data by Application
5.1 Global TIGIT Therapies Historic Market Size by Application (2018-2024)
5.2 Global TIGIT Therapies Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America TIGIT Therapies Market Size (2018-2029)
6.2 North America TIGIT Therapies Market Size by Type
6.2.1 North America TIGIT Therapies Market Size by Type (2018-2024)
6.2.2 North America TIGIT Therapies Market Size by Type (2024-2029)
6.2.3 North America TIGIT Therapies Market Share by Type (2018-2029)
6.3 North America TIGIT Therapies Market Size by Application
6.3.1 North America TIGIT Therapies Market Size by Application (2018-2024)
6.3.2 North America TIGIT Therapies Market Size by Application (2024-2029)
6.3.3 North America TIGIT Therapies Market Share by Application (2018-2029)
6.4 North America TIGIT Therapies Market Size by Country
6.4.1 North America TIGIT Therapies Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America TIGIT Therapies Market Size by Country (2018-2024)
6.4.3 North America TIGIT Therapies Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe TIGIT Therapies Market Size (2018-2029)
7.2 Europe TIGIT Therapies Market Size by Type
7.2.1 Europe TIGIT Therapies Market Size by Type (2018-2024)
7.2.2 Europe TIGIT Therapies Market Size by Type (2024-2029)
7.2.3 Europe TIGIT Therapies Market Share by Type (2018-2029)
7.3 Europe TIGIT Therapies Market Size by Application
7.3.1 Europe TIGIT Therapies Market Size by Application (2018-2024)
7.3.2 Europe TIGIT Therapies Market Size by Application (2024-2029)
7.3.3 Europe TIGIT Therapies Market Share by Application (2018-2029)
7.4 Europe TIGIT Therapies Market Size by Country
7.4.1 Europe TIGIT Therapies Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe TIGIT Therapies Market Size by Country (2018-2024)
7.4.3 Europe TIGIT Therapies Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China TIGIT Therapies Market Size (2018-2029)
8.2 China TIGIT Therapies Market Size by Type
8.2.1 China TIGIT Therapies Market Size by Type (2018-2024)
8.2.2 China TIGIT Therapies Market Size by Type (2024-2029)
8.2.3 China TIGIT Therapies Market Share by Type (2018-2029)
8.3 China TIGIT Therapies Market Size by Application
8.3.1 China TIGIT Therapies Market Size by Application (2018-2024)
8.3.2 China TIGIT Therapies Market Size by Application (2024-2029)
8.3.3 China TIGIT Therapies Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia TIGIT Therapies Market Size (2018-2029)
9.2 Asia TIGIT Therapies Market Size by Type
9.2.1 Asia TIGIT Therapies Market Size by Type (2018-2024)
9.2.2 Asia TIGIT Therapies Market Size by Type (2024-2029)
9.2.3 Asia TIGIT Therapies Market Share by Type (2018-2029)
9.3 Asia TIGIT Therapies Market Size by Application
9.3.1 Asia TIGIT Therapies Market Size by Application (2018-2024)
9.3.2 Asia TIGIT Therapies Market Size by Application (2024-2029)
9.3.3 Asia TIGIT Therapies Market Share by Application (2018-2029)
9.4 Asia TIGIT Therapies Market Size by Region
9.4.1 Asia TIGIT Therapies Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia TIGIT Therapies Market Size by Region (2018-2024)
9.4.3 Asia TIGIT Therapies Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America TIGIT Therapies Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Type
10.2.1 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America TIGIT Therapies Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Application
10.3.1 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America TIGIT Therapies Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Country
10.4.1 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America TIGIT Therapies Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche TIGIT Therapies Introduction
11.1.4 Roche Revenue in TIGIT Therapies Business (2018-2024)
11.1.5 Roche Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck TIGIT Therapies Introduction
11.2.4 Merck Revenue in TIGIT Therapies Business (2018-2024)
11.2.5 Merck Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca TIGIT Therapies Introduction
11.3.4 AstraZeneca Revenue in TIGIT Therapies Business (2018-2024)
11.3.5 AstraZeneca Recent Developments
11.4 Arcus
11.4.1 Arcus Company Details
11.4.2 Arcus Business Overview
11.4.3 Arcus TIGIT Therapies Introduction
11.4.4 Arcus Revenue in TIGIT Therapies Business (2018-2024)
11.4.5 Arcus Recent Developments
11.5 Astellas
11.5.1 Astellas Company Details
11.5.2 Astellas Business Overview
11.5.3 Astellas TIGIT Therapies Introduction
11.5.4 Astellas Revenue in TIGIT Therapies Business (2018-2024)
11.5.5 Astellas Recent Developments
11.6 BeiGene
11.6.1 BeiGene Company Details
11.6.2 BeiGene Business Overview
11.6.3 BeiGene TIGIT Therapies Introduction
11.6.4 BeiGene Revenue in TIGIT Therapies Business (2018-2024)
11.6.5 BeiGene Recent Developments
11.7 BMS
11.7.1 BMS Company Details
11.7.2 BMS Business Overview
11.7.3 BMS TIGIT Therapies Introduction
11.7.4 BMS Revenue in TIGIT Therapies Business (2018-2024)
11.7.5 BMS Recent Developments
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Details
11.8.2 Junshi Biosciences Business Overview
11.8.3 Junshi Biosciences TIGIT Therapies Introduction
11.8.4 Junshi Biosciences Revenue in TIGIT Therapies Business (2018-2024)
11.8.5 Junshi Biosciences Recent Developments
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Details
11.9.2 Innovent Biologics Business Overview
11.9.3 Innovent Biologics TIGIT Therapies Introduction
11.9.4 Innovent Biologics Revenue in TIGIT Therapies Business (2018-2024)
11.9.5 Innovent Biologics Recent Developments
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Details
11.10.2 Mereo BioPharma Business Overview
11.10.3 Mereo BioPharma TIGIT Therapies Introduction
11.10.4 Mereo BioPharma Revenue in TIGIT Therapies Business (2018-2024)
11.10.5 Mereo BioPharma Recent Developments
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Details
11.11.2 Seattle Genetics Business Overview
11.11.3 Seattle Genetics TIGIT Therapies Introduction
11.11.4 Seattle Genetics Revenue in TIGIT Therapies Business (2018-2024)
11.11.5 Seattle Genetics Recent Developments
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Details
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine TIGIT Therapies Introduction
11.12.4 Hengrui Medicine Revenue in TIGIT Therapies Business (2018-2024)
11.12.5 Hengrui Medicine Recent Developments
11.13 Compugen
11.13.1 Compugen Company Details
11.13.2 Compugen Business Overview
11.13.3 Compugen TIGIT Therapies Introduction
11.13.4 Compugen Revenue in TIGIT Therapies Business (2018-2024)
11.13.5 Compugen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global TIGIT Therapies Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global TIGIT Therapies Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global TIGIT Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global TIGIT Therapies Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global TIGIT Therapies Market Share by Region (2018-2024)
Table 8. Global TIGIT Therapies Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global TIGIT Therapies Market Share by Region (2024-2029)
Table 10. TIGIT Therapies Market Trends
Table 11. TIGIT Therapies Market Drivers
Table 12. TIGIT Therapies Market Challenges
Table 13. TIGIT Therapies Market Restraints
Table 14. Global TIGIT Therapies Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global TIGIT Therapies Revenue Share by Players (2018-2024)
Table 16. Global Top TIGIT Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TIGIT Therapies as of 2022)
Table 17. Global TIGIT Therapies Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by TIGIT Therapies Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of TIGIT Therapies, Headquarters and Area Served
Table 20. Global Key Players of TIGIT Therapies, Product and Application
Table 21. Global Key Players of TIGIT Therapies, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TIGIT Therapies Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global TIGIT Therapies Revenue Market Share by Type (2018-2024)
Table 25. Global TIGIT Therapies Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global TIGIT Therapies Revenue Market Share by Type (2024-2029)
Table 27. Global TIGIT Therapies Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global TIGIT Therapies Revenue Share by Application (2018-2024)
Table 29. Global TIGIT Therapies Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global TIGIT Therapies Revenue Share by Application (2024-2029)
Table 31. North America TIGIT Therapies Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America TIGIT Therapies Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America TIGIT Therapies Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America TIGIT Therapies Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America TIGIT Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America TIGIT Therapies Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America TIGIT Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe TIGIT Therapies Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe TIGIT Therapies Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe TIGIT Therapies Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe TIGIT Therapies Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe TIGIT Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe TIGIT Therapies Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe TIGIT Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 45. China TIGIT Therapies Market Size by Type (2018-2024) & (US$ Million)
Table 46. China TIGIT Therapies Market Size by Type (2024-2029) & (US$ Million)
Table 47. China TIGIT Therapies Market Size by Application (2018-2024) & (US$ Million)
Table 48. China TIGIT Therapies Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia TIGIT Therapies Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia TIGIT Therapies Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia TIGIT Therapies Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia TIGIT Therapies Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia TIGIT Therapies Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia TIGIT Therapies Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia TIGIT Therapies Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America TIGIT Therapies Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America TIGIT Therapies Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America TIGIT Therapies Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America TIGIT Therapies Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America TIGIT Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America TIGIT Therapies Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America TIGIT Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche TIGIT Therapies Product
Table 66. Roche Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 67. Roche Recent Developments
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck TIGIT Therapies Product
Table 71. Merck Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 72. Merck Recent Developments
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca TIGIT Therapies Product
Table 76. AstraZeneca Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 77. AstraZeneca Recent Developments
Table 78. Arcus Company Details
Table 79. Arcus Business Overview
Table 80. Arcus TIGIT Therapies Product
Table 81. Arcus Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 82. Arcus Recent Developments
Table 83. Astellas Company Details
Table 84. Astellas Business Overview
Table 85. Astellas TIGIT Therapies Product
Table 86. Astellas Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 87. Astellas Recent Developments
Table 88. BeiGene Company Details
Table 89. BeiGene Business Overview
Table 90. BeiGene TIGIT Therapies Product
Table 91. BeiGene Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 92. BeiGene Recent Developments
Table 93. BMS Company Details
Table 94. BMS Business Overview
Table 95. BMS TIGIT Therapies Product
Table 96. BMS Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 97. BMS Recent Developments
Table 98. Junshi Biosciences Company Details
Table 99. Junshi Biosciences Business Overview
Table 100. Junshi Biosciences TIGIT Therapies Product
Table 101. Junshi Biosciences Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 102. Junshi Biosciences Recent Developments
Table 103. Innovent Biologics Company Details
Table 104. Innovent Biologics Business Overview
Table 105. Innovent Biologics TIGIT Therapies Product
Table 106. Innovent Biologics Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 107. Innovent Biologics Recent Developments
Table 108. Mereo BioPharma Company Details
Table 109. Mereo BioPharma Business Overview
Table 110. Mereo BioPharma TIGIT Therapies Product
Table 111. Mereo BioPharma Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 112. Mereo BioPharma Recent Developments
Table 113. Seattle Genetics Company Details
Table 114. Seattle Genetics Business Overview
Table 115. Seattle Genetics TIGIT Therapies Product
Table 116. Seattle Genetics Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 117. Seattle Genetics Recent Developments
Table 118. Hengrui Medicine Company Details
Table 119. Hengrui Medicine Business Overview
Table 120. Hengrui Medicine TIGIT Therapies Product
Table 121. Hengrui Medicine Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 122. Hengrui Medicine Recent Developments
Table 123. Compugen Company Details
Table 124. Compugen Business Overview
Table 125. Compugen TIGIT Therapies Product
Table 126. Compugen Revenue in TIGIT Therapies Business (2018-2024) & (US$ Million)
Table 127. Compugen Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TIGIT Therapies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global TIGIT Therapies Market Share by Type: 2022 VS 2029
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Global TIGIT Therapies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global TIGIT Therapies Market Share by Application: 2022 VS 2029
Figure 7. Cell Carcinoma Case Studies
Figure 8. Solid Tumor Case Studies
Figure 9. TIGIT Therapies Report Years Considered
Figure 10. Global TIGIT Therapies Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global TIGIT Therapies Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global TIGIT Therapies Market Share by Region: 2022 VS 2029
Figure 13. Global TIGIT Therapies Market Share by Players in 2022
Figure 14. Global Top TIGIT Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TIGIT Therapies as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by TIGIT Therapies Revenue in 2022
Figure 16. North America TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America TIGIT Therapies Market Share by Type (2018-2029)
Figure 18. North America TIGIT Therapies Market Share by Application (2018-2029)
Figure 19. North America TIGIT Therapies Market Share by Country (2018-2029)
Figure 20. United States TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe TIGIT Therapies Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe TIGIT Therapies Market Share by Type (2018-2029)
Figure 24. Europe TIGIT Therapies Market Share by Application (2018-2029)
Figure 25. Europe TIGIT Therapies Market Share by Country (2018-2029)
Figure 26. Germany TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China TIGIT Therapies Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China TIGIT Therapies Market Share by Type (2018-2029)
Figure 34. China TIGIT Therapies Market Share by Application (2018-2029)
Figure 35. Asia TIGIT Therapies Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia TIGIT Therapies Market Share by Type (2018-2029)
Figure 37. Asia TIGIT Therapies Market Share by Application (2018-2029)
Figure 38. Asia TIGIT Therapies Market Share by Region (2018-2029)
Figure 39. Japan TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America TIGIT Therapies Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America TIGIT Therapies Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America TIGIT Therapies Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America TIGIT Therapies Market Share by Country (2018-2029)
Figure 49. Brazil TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries TIGIT Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Roche Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 56. Merck Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 57. AstraZeneca Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 58. Arcus Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 59. Astellas Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 60. BeiGene Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 61. BMS Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 62. Junshi Biosciences Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 63. Innovent Biologics Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 64. Mereo BioPharma Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 65. Seattle Genetics Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 66. Hengrui Medicine Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 67. Compugen Revenue Growth Rate in TIGIT Therapies Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries